CTIM-76

Context Therapeutics Inc. · Phase 1 active Small molecule

At a glance

Generic name	CTIM-76
Also known as	CTIM-76 Claudin 6 bispecific Antibody
Sponsor	Context Therapeutics Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CTIM-76 CI brief — competitive landscape report
CTIM-76 updates RSS · CI watch RSS
Context Therapeutics Inc. portfolio CI